More Vaccines for SA – but with Conditions

Sinovac
Share on whatsapp
Share on facebook
Share on twitter
Share on linkedin
Share on google
Share on email
Share on print

The South African Health Products Regulatory Authority (Sahpra) has approved the Sinovac-CoronaVac vaccine for use in South Africa. The Chinese-produced vaccine is a two-dose innoculation  recommended for patients 18-years and older, with  51% efficacy against the coronavirus. Now that Sahpra approved an additional vaccine to choose from in the country’s inoculation drive, health experts are hopeful it would be able to slow down the spread of the virus. South Africa is experiencing its third wave, spurred by the Delta variant.

Guest: Dr. Boitumelo Semete – CEO, South African Health Products Regulatory Authority


More Posts for Show: NRA

News Headlines

July 30, 2021
Fajr Athaan

06:17

3 Hours 14 Minutes
Prayer Begins Athaan
Fajr06:14 06:17
Sunrise07:40
Jumuah12:53 12:56
Asr15:45 15:48
Maghrib18:06 18:09
Isha19:27 19:30
LIVE OFFLINE
Loading...
Open chat